Molecular Analysis and Testing of New Treatments for Diffuse Midline Gliomas
Molecular Analysis and Testing of New Treatments for Diffuse Midline Gliomas
Diffuse Midline Gliomas in Children Pediatric brain tumors are the leading cause of cancer-related mortality in children. Diffuse midline gliomas are the most common and severe form of malignant gliomas in children and adolescents (between 50 and 100 new cases are expected each year in France). Most affected children die within two years of diagnosis. […]
SACHA : le programme qui sécurise l’accès aux médicaments en dehors des essais cliniques
SACHA : le programme qui sécurise l’accès aux médicaments en dehors des essais cliniques
Context of the SACHA Study France stands as a pioneer in Europe in the field of developing new drugs in pediatric oncology. For example, from 2015 to 2018, over 2,200 patients were enrolled in 34 clinical trials by ITCC (Innovative Therapies for Children with Cancer). Among them, 53% of the patients were recruited in France. […]
FIGHT KIDS CANCER 2024 LAUNCHES A CALL FOR EUROPEAN PROJECTS DEDICATED TO BRAIN TUMORS
FIGHT KIDS CANCER 2024 LAUNCHES A CALL FOR EUROPEAN PROJECTS DEDICATED TO BRAIN TUMORS
On the occasion of September in GOLD, Fight Kids Cancer, an initiative created by Imagine for Margo and its European partners, is launching a new call for projects to boost research against childhood brain tumors Brain tumors represent the second most common form of childhood cancer after leukemia. Among solid tumors in children, those of […]
SACHA: Accelerate children’s access to innovative molecules – Interview with Dr. Pablo Berlanga
SACHA: Accelerate children’s access to innovative molecules – Interview with Dr. Pablo Berlanga
France is a pioneer in Europe in the development of new drugs in pediatric oncology. For example, within the ITCC network (Innovative Therapies for Children and adolescents with Cancer, 14 countries), France accounts for 50% of inclusions in early clinical trials. Since 2014, specific measures have been put in place in France as part of […]
BIOMEDE: HOPE FOR Diffuse Intrinsic pontine glioma
BIOMEDE: HOPE FOR Diffuse Intrinsic pontine glioma
BIOMEDE is the most ambitious clinical trial ever proposed for children with a Diffuse Intrinsic pontine glioma. This malignant brain tumor is highly aggressive and is located in a vital area of the brainstem called the pons. This cerebral region controls vital functions such as balance, breathing, heart rate, blood pressure, and is also traversed […]
BIOMEDE: A Therapeutic Revolution for Diffuse Intrinsec Pontine Glioma (DIPG)
BIOMEDE: A Therapeutic Revolution for Diffuse Intrinsec Pontine Glioma (DIPG)
BIOMEDE is the most ambitious clinical trial offered to children suffering from DIPG. This malignant brain tumor is highly aggressive and is located in a vital area of the brainstem called the pons. This cerebral region controls essential functions such as balance, breathing, heart rate and blood pressure. It is also traversed by nerves that […]
IMAGINE FOR MARGO X INSTITUT CURIE: 10 YEARS OF SHARED HISTORY AGAINST CHILDREN’S CANCER
IMAGINE FOR MARGO X INSTITUT CURIE: 10 YEARS OF SHARED HISTORY AGAINST CHILDREN’S CANCER
This Thursday, September 14, 2023, we organized with the Institut Curie an evening dedicated to the 10 years of our collaboration. Researchers, pediatricians, donors and volunteers came together to celebrate 10 years of innovations for the benefit of children and adolescents with cancer. Among the 42 research programs that we have funded since 2011, 12 […]
FIGHT KIDS CANCER 2023: 9 EUROPEAN RESEARCH PROGRAMS SELECTED
FIGHT KIDS CANCER 2023: 9 EUROPEAN RESEARCH PROGRAMS SELECTED
Fight Kids Cancer is a European call for projects that we launched in 2020 with the Belgian KickCancer Foundation and the Luxembourg Kriibskrank Kanner Foundation in collaboration with the ESF – European Science Foundation – and a committee of international scientific experts. Today, Fight Kids Cancer has 6 member countries. Indeed, Cris (Spain) and KiKa […]
